Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Aviso Wealth Management

Aviso Wealth Management lessened its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.5% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 402 shares of the medical equipment provider’s stock after selling 28 shares during the period. Aviso Wealth Management’s holdings in Intuitive Surgical were worth $210,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Vanguard Group Inc. lifted its holdings in shares of Intuitive Surgical by 1.1% during the fourth quarter. Vanguard Group Inc. now owns 32,212,196 shares of the medical equipment provider’s stock worth $16,813,478,000 after purchasing an additional 360,591 shares during the period. State Street Corp raised its holdings in Intuitive Surgical by 1.4% during the third quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock worth $7,393,673,000 after purchasing an additional 210,363 shares in the last quarter. FMR LLC increased its position in Intuitive Surgical by 8.3% during the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock worth $5,389,765,000 after purchasing an additional 838,793 shares during the period. Geode Capital Management LLC raised its position in Intuitive Surgical by 1.9% in the third quarter. Geode Capital Management LLC now owns 7,512,925 shares of the medical equipment provider’s stock worth $3,677,194,000 after acquiring an additional 143,440 shares in the last quarter. Finally, Fisher Asset Management LLC lifted its holdings in Intuitive Surgical by 1.8% in the fourth quarter. Fisher Asset Management LLC now owns 4,868,869 shares of the medical equipment provider’s stock valued at $2,541,356,000 after acquiring an additional 86,488 shares during the period. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, VP Fredrik Widman sold 810 shares of the firm’s stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $573.78, for a total transaction of $464,761.80. Following the completion of the sale, the vice president now owns 473 shares in the company, valued at $271,397.94. This trade represents a 63.13 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Mark Brosius sold 492 shares of the firm’s stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $573.78, for a total transaction of $282,299.76. Following the sale, the senior vice president now directly owns 4,056 shares of the company’s stock, valued at $2,327,251.68. The trade was a 10.82 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 33,754 shares of company stock valued at $17,691,621 in the last ninety days. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Trading Up 2.2 %

ISRG opened at $519.81 on Wednesday. Intuitive Surgical, Inc. has a twelve month low of $364.17 and a twelve month high of $616.00. The firm has a market cap of $185.15 billion, a price-to-earnings ratio of 81.09, a PEG ratio of 5.85 and a beta of 1.43. The company has a fifty day simple moving average of $561.24 and a 200 day simple moving average of $532.59.

Analyst Ratings Changes

A number of brokerages have recently issued reports on ISRG. BTIG Research increased their price target on shares of Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a report on Tuesday, November 26th. Raymond James boosted their price target on Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a research note on Friday, January 24th. Erste Group Bank downgraded Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research note on Monday, March 17th. Leerink Partners boosted their target price on Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. Finally, Wells Fargo & Company increased their price target on shares of Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have issued a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $611.86.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.